Two Sigma Securities’s Ampio Pharmaceuticals AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,507
Closed -$7.02K – 3669
2023
Q2
$7.02K Buy
1,507
+813
+117% +$3.98K ﹤0.01% 2638
2023
Q1
$3.24K Buy
+694
New +$3.9K ﹤0.01% 2545
2022
Q4
– Sell
-91
Closed -$2K – 3509
2022
Q3
$2K Sell
91
-75
-45% -$2.63K ﹤0.01% 2527
2022
Q2
$8K Buy
+166
New +$12.4K ﹤0.01% 2082
2022
Q1
– Sell
-84
Closed -$14K – 2676
2021
Q4
$14K Buy
+84
New +$31.3K ﹤0.01% 1451
2020
Q4
– Sell
-40
Closed -$12K – 2043
2020
Q3
$12K Buy
+40
New +$9.9K ﹤0.01% 1245
2018
Q2
– Sell
-35
Closed -$36K – 3119
2018
Q1
$36K Buy
+35
New +$29.3K ﹤0.01% 2530

Other funds holding AMPE

Two Sigma Securities's AMPE Position: Q3 2023 in Review

Two Sigma Securities sold out of Ampio Pharmaceuticals (AMPE) in Q3 2023, closing a stake of 1,507 shares — an estimated $7.02K sold.

Two Sigma Securities first reported a position in AMPE in Q1 2018 and held it in 7 quarters. The position peaked at $36K in Q1 2018. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • Two Sigma Securities reported no remaining Ampio Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 1,507 Ampio Pharmaceuticals shares in Q3 2023, an estimated $7.02K.
  • Two Sigma Securities first reported a position in Ampio Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Two Sigma Securities's Ampio Pharmaceuticals position peaked at $36K in Q1 2018.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.